| Literature DB >> 29570997 |
Abstract
Biallelic mutations in the RPE65 gene are associated with inherited retinal degenerations/dystrophies (IRD) and disrupt the visual cycle, leading to loss of vision. A new adenoviral vector-based gene therapy surgically delivered to retinal cells provides normal human RPE65 protein that can restore the visual cycle and some vision. To view this Bench to Bedside, open or download the PDF.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29570997 DOI: 10.1016/j.cell.2018.03.021
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582